Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria (DIAMOND)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03190694
Recruitment Status : Recruiting
First Posted : June 19, 2017
Last Update Posted : October 5, 2018
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Hiddo Lambers Heerspink, University Medical Center Groningen

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : July 16, 2019
  Estimated Study Completion Date : December 1, 2019